<DOC>
	<DOCNO>NCT01001949</DOCNO>
	<brief_summary>The investigational product use study soft drink contain arabinoxylan-oligosaccharide ( AXOS ) preparation extract wheat bran ( hereafter call Wheat Bran Extract , WBE ) . The objective study analyze effect intake WBE various parameter gastrointestinal health child ( 8-12 yr ) . Additionally , safety analyze use treatment emergent Adverse Events ( AEs ) .</brief_summary>
	<brief_title>In Vivo Evaluation Physiological Effects Arabinoxylan-oligosaccharides ( AXOS ) Healthy Subjects ( Juniors )</brief_title>
	<detailed_description />
	<criteria>regular eat habits consent take study product accord study protocol consent parent followup protocol subject willing maintain his/her habitual food beverage intake throughout study period ( exception omission prebiotic probiotic food product indicate study protocol ) lowcalorie diet extreme dietary habit 6 week start clinical trial recent use antibiotic abdominal surgery past use medication dietary supplement know influence gastrointestinal tract within two week start clinical trial . Examples medication/dietary supplement antispasmodic , antidiarrhea medication and/or probiotic medication serious illness within 3 month start clinical trial chronic gastrointestinal condition inflammatory bowel disease ( IBD ) , irritable bowel syndrome ( IBS ) , chronic constipation , history frequent diarrhea , clinically important lactose intolerance complete anesthetic within 3 month start clinical trial allergy wheat product celiac disease Subject condition Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put subject undue risk</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>